These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 20002769

  • 1. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV, Kovacs G.
    Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
    [Abstract] [Full Text] [Related]

  • 2. Expression of vitamin D3 receptor in kidney tumors.
    Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [Abstract] [Full Text] [Related]

  • 3. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G, Barthelemy A, Feng G, Gentil-Perret A, Peoc'h M, Genin C, Tostain J.
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

  • 5. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 6. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 7. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N, Inoue K, Guo L, Miyazaki E, Hayashi Y, Naruse K, Toi M, Hiroi M, Shuin T, Enzan H.
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 9. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS.
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [Abstract] [Full Text] [Related]

  • 10. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C, Liu QG, Zhang L, Song T, Yang X.
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [Abstract] [Full Text] [Related]

  • 11. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E, Matoso A, Sabo E, Wang LJ, Tavares R, Meitner P, Morris DJ, Pareek G, Delellis RA, Resnick MB.
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [Abstract] [Full Text] [Related]

  • 12. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC, Chen PC, Ho DM.
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [Abstract] [Full Text] [Related]

  • 14. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J, Thiesson H, Walter S, Ottosen PD, Skøtt O, Jensen BL.
    Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI, Shin MK, Lee JW, Chung JH, Lee MH.
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [Abstract] [Full Text] [Related]

  • 16. Expression of S-100 protein in renal cell neoplasms.
    Lin F, Yang W, Betten M, Teh BT, Yang XJ, French Kidney Cancer Study Group.
    Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
    [Abstract] [Full Text] [Related]

  • 17. Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours.
    Yusenko MV, Zubakov D, Kovacs G.
    Int J Biol Sci; 2009 Jul 29; 5(6):517-27. PubMed ID: 19680475
    [Abstract] [Full Text] [Related]

  • 18. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A, Buzogany I, Kovacs G.
    Histopathology; 2004 Jun 29; 44(6):542-6. PubMed ID: 15186268
    [Abstract] [Full Text] [Related]

  • 19. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, Furge KA, Kanayama H, Kagawa S, Teh BT.
    Oncogene; 2003 Oct 02; 22(43):6810-8. PubMed ID: 14555994
    [Abstract] [Full Text] [Related]

  • 20. Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas.
    Chen Y, Yusenko MV, Kovacs G.
    J Pathol; 2011 Jan 02; 223(1):46-53. PubMed ID: 20922711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.